http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015213503-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faf522b8b83eded745c73018576219ba |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
| filingDate | 2015-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d69a72bfba3f87af7281d993efbc19f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8586d217f5f2589ce666624d86d68452 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_220eed4066cc3652ef6370aacea658e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d359604bffa30490fced866a4e7b9138 |
| publicationDate | 2015-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2015213503-A |
| titleOfInvention | Method and kit for predicting cancer prognosis, screening method for cancer therapeutic agent, cancer cell growth inhibitor, cancer therapeutic agent, and method and kit for predicting the efficacy of mTOR inhibitor |
| abstract | A method and kit for predicting the prognosis of cancer that can easily and easily predict the prognosis of various cancers, a cancer cell proliferation inhibitor having excellent cancer cell growth-inhibiting ability, A cancer therapeutic agent containing a cancer cell growth inhibitor, a method for screening a cancer therapeutic agent, a method for predicting the efficacy of an mTOR inhibitor capable of easily and easily predicting the efficacy of an mTOR inhibitor, and Providing kits. A method of measuring at least one of the expression level and activity of TUFT1 in a patient-derived sample, and a step of evaluating the prognosis of cancer using at least one of the expression level and activity of TUFT1 as an index. A method for predicting the prognosis of cancer, a method for predicting the efficacy of an mTOR inhibitor, and the like. [Selection figure] None |
| priorityDate | 2014-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 405.